Management of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future Perspectives.
- Published in:
- Drugs, 2016, v. 76, n. 4, p. 459, doi. 10.1007/s40265-015-0534-3
- By:
- Publication type:
- Article
Works matching IS 00126667 AND DT 2016 AND VI 76 AND IP 4
Results: 8
1
2
Lesinurad: First Global Approval.
- Published in:
- Drugs, 2016, v. 76, n. 4, p. 509, doi. 10.1007/s40265-016-0550-y
- By:
- Publication type:
- Article
3
Brivaracetam: First Global Approval.
- Published in:
- Drugs, 2016, v. 76, n. 4, p. 517, doi. 10.1007/s40265-016-0555-6
- By:
- Publication type:
- Article
4
Dichlorphenamide: A Review in Primary Periodic Paralyses.
- Published in:
- Drugs, 2016, v. 76, n. 4, p. 501, doi. 10.1007/s40265-016-0559-2
- By:
- Publication type:
- Article
5
Liposomal Amphotericin B (AmBisome): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions.
- Published in:
- Drugs, 2016, v. 76, n. 4, p. 485, doi. 10.1007/s40265-016-0538-7
- By:
- Publication type:
- Article
6
Pharmacotherapy for Fragile X Syndrome: Progress to Date.
- Published in:
- Drugs, 2016, v. 76, n. 4, p. 431, doi. 10.1007/s40265-016-0542-y
- By:
- Publication type:
- Article
7
Therapeutic Strategies for the Treatment of Severe Cushing's Syndrome.
- Published in:
- Drugs, 2016, v. 76, n. 4, p. 447, doi. 10.1007/s40265-016-0539-6
- By:
- Publication type:
- Article
8
Managing Metastatic Castration-Resistant Prostate Cancer in the Pre-chemotherapy Setting: A Changing Approach in the Era of New Targeted Agents.
- Published in:
- Drugs, 2016, v. 76, n. 4, p. 421, doi. 10.1007/s40265-015-0530-7
- By:
- Publication type:
- Article